DexCom had 27 patents in cybersecurity during Q4 2023. DexCom Inc’s patents filed in Q4 2023 focus on inter-app communications on mobile devices, transmitting data from analyte sensors, and controlling the use of glucose data. The patents detail methods for transitioning data between software applications, establishing communication channels between devices, and classifying and routing data based on type. These innovations aim to improve the efficiency and accuracy of data transmission and utilization in healthcare monitoring systems. GlobalData’s report on DexCom gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom grant share with cybersecurity as a theme is 33% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Methods for providing an alert or an alarm to a user of a mobile communications device (Patent ID: US20230414873A1)
The patent filed by DexCom Inc. discloses methods, devices, and systems for inter-app communications on a mobile communications device. The invention involves a computer-readable medium with an inter-application communication data structure that facilitates transitioning and distributing data between software applications in a shared app group. This data structure includes a scheme field with a scheme id associated with a target software app and a payload field providing data or an identification to access data in a shared file system, which is encrypted.
The patent claims describe a mobile communications device with different software modules for receiving glucose measurements from a monitoring system, determining insulin dosage based on the measurements, and transmitting commands to an insulin delivery device. The device can store glucose measurements in a shared database, retrieve them, and encrypt information using a symmetric database key. The method involves receiving glucose measurements, calculating insulin dosage, and transmitting commands to administer the dosage. The patent also covers a non-transitory computer-readable medium with instructions for executing the method described. Overall, the patent focuses on enhancing communication and data sharing between software applications on mobile devices for efficient healthcare management.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
